The University of Bristol Proteomics Facility provides a service for researchers across Bristol University and beyond.


The Facility was created in its present form in 2004 upon the recruitment of Dr Kate Heesom from the Proteomics Methods Development Team at Oxford Glycosciences (UK) Ltd. Building on gel-based proteomics equipment purchased through a Wellcome Trust - JIF award in 1999, in 2011 the facility acquired an LTQ-Orbitrap Velos mass spectrometer with funding from the Wolfson foundation and the University of Bristol, allowing the development of LCMS-based proteomic applications. In 2015 capability within the Facility was further enhanced by the purchase of an Orbitrap Fusion Tribrid mass spectrometer with ETD, funded by the Wellcome Trust and the University of Bristol.

The facility provides a service to multiple research groups across the University of Bristol, but also to many groups from major UK Universities and to industrial partners. The Facility’s user base encompasses a diverse range of research areas, including cell biology, neuroscience, cardiovascular science, infection and immunity, cancer research, evolutionary biology, oral health, small animal medicine and plant and agricultural sciences.

Our dedicated and highly experienced staff can provide advice on all stages of proteomics projects from experimental design and sample preparation through to data analysis.

Further information about our services and equipment are available on the web site.

The Wills Building
Edit this page